Banka BioLoo Limited has informed the Exchange about Investor Presentation
BANKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Banka BioLoo filed its Q1 FY26 investor presentation with NSE. Revenue was largely flat at ₹1,255.82 lakhs versus ₹1,238.7 lakhs in Q1 FY25, a marginal 1.4% rise. However, profitability weakened sharply — standalone EBITDA fell to ₹103.25 lakhs (8% margin) from ₹163.7 lakhs, and PAT dropped to ₹13.54 lakhs from ₹42.3 lakhs YoY. Consolidated PAT was nearly zero at ₹0.21 lakhs, indicating pressure at the group level. The company booked new orders worth ~₹31 crs in Q1 (Railways ~₹21.6 crs, WaSH ~₹9.3 crs), with total unexecuted order book of ~₹113 crs across both segments.
Despite stable revenue, sharp YoY decline in EBITDA and PAT signals margin pressure and weak operating leverage. The strong order pipeline (~₹113 crs) offers revenue visibility, but WaSH execution has been slow with pickup expected only in Q2-Q3, which may keep near-term stock sentiment cautious.